Laddar...
Targeting the ubiquitin-mediated proteasome degradation of p53 for cancer therapy
Within the past decade, there has been a revolution in the types of drugs developed to treat cancer. Therapies that selectively target cancer-specific aberrations, such as kinase inhibitors, have made a dramatic impact on a subset of patients. In spite of these successes, there is still a dearth of...
Sparad:
| Huvudupphovsmän: | , |
|---|---|
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
2013
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3637405/ https://ncbi.nlm.nih.gov/pubmed/23151129 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|